Table 1.
Experimental Group | |||||
---|---|---|---|---|---|
Group A | Group B | ||||
Parameters | Normal Range [8,10,11] | Control | Treatment | Control | Treatment |
Reb blood count (RBC)—×106 µL | 5.50–8.50 | 7.46 ± 0.64 | 7.39 ± 0.83 | 7.55 ± 0.70 | 7.25 ± 0.56 |
Hematocrit (Hct)—% | 37.00–55.00 | 53.86 ± 7.02 | 53.63 ± 7.04 | 53.58 ± 5.68 | 53.60 ± 4.17 |
Hemoglobin (Hgb)—g/dL | 12.00–18.00 | 16.24 ± 1.04 | 16.08 ± 1.59 | 16.50 ± 1.20 | 16.64 ± 0.86 |
Platelet (PLT)—×103 µL | 200.00–500.00 | 301.78 ± 101.25 | 298.15 ± 108.38 | 305.25 ± 105.15 | 316.28 ± 102.35 |
White blood count (WBC)—×103 µL | 6.00–17.00 | 8.45 ± 1.16 | 8.68 ± 1.45 | 8.48 ± 1.35 | 8.31 ± 0.96 |
Reactive oxygen species (dROMs)—(U carr) | 56–91 | 165.39 ± 6.69 | 163.79 ± 5.62 | 179.20 ± 9.51 | 175.10 ± 7.85 |
Thiol antioxidant barrier (SHp)—µmol/L | 450–650 | 430.54 ± 10.19 | 433.60 ± 12.78 | 335.10 ± 11.51 | 337.16 ± 9.58 |
Aspartate aminotransferase (AST)—U/L | 23.00–66.00 | 41.50 ± 8.79 | 39.40 ± 10.15 | 85.10 ± 11.23 | 80.50 ± 16.53 |
Alanine aminotransferase (ALT)—U/L | 21.00–102.00 | 46.80 ± 8.05 | 47.70 ± 11.57 | 55.10 ± 12.88 | 49.60 ± 20.15 |
Alkaline phosphatase (ALP)—U/L | 20.00–156.00 | 32.10 ± 7.63 | 32.40 ± 8.50 | 32.60 ± 9.33 | 32.90 ± 10.31 |
Lactate dehydrogenase (LDH)—U/L | 45.00–233.00 | 83.40 ± 6.39 | 82.20 ± 7.56 | 47.40 ± 21.94 | 47.50 ± 22.75 |
Creatinkinase (CK)—U/L | 1.15–28.40 | 15.21 ± 2.38 | 13.58 ± 3.75 | 16.39 ± 3.05 | 14.78 ± 2.45 |
Total Bilirubin—mg/dL | 0.06–0.12 | 0.09 ± 0.17 | 0.09 ± 0.007 | 0.09 ± 0.09 | 0.10 ± 0.07 |
Creatinine—mg/dL | 0.50–1.50 | 0.92 ± 0.26 | 0.92 ± 0.26 | 0.86 ± 0.23 | 1.00 ± 0.38 |
Urea—mg/dL | 10.00–20.00 | 14.90 ± 3.17 | 15.10 ± 4.45 | 15.00 ± 3.23 | 15.20 ± 4.15 |
Glucose—mg/dL | 65.00–118.00 | 94.40 ± 15.88 | 88.30 ± 22.90 | 75.60 ± 6.83 | 76.70 ± 9.14 |
Total Protein—g/dL | 5.40–7.10 | 6.25 ± 0.54 | 6.51 ± 0.36 | 6.52 ± 0.60 | 6.45 ± 0.49 |
Albumin—g/dL | 2.60–3.30 | 2.94 ± 0.24 | 2.85 ± 0.27 | 2.92 ± 0.23 | 2.83 ± 0.43 |